These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2933014)

  • 21. Early grey matter changes in structural covariance networks in Huntington's disease.
    Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA
    Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of stable xenon inhalation on intracranial pressure during measurement of cerebral blood flow in head injury.
    Plougmann J; Astrup J; Pedersen J; Gyldensted C
    J Neurosurg; 1994 Dec; 81(6):822-8. PubMed ID: 7965111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CT brainstem abnormalities in the differential diagnosis of Huntington's disease.
    Masucci EF; Borts FT; Kurtzke JF
    Comput Med Imaging Graph; 1990; 14(3):205-12. PubMed ID: 2140710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resting-state fMRI reveals potential neural correlates of impaired cognition in Huntington's disease.
    Liu W; Yang J; Chen K; Luo C; Burgunder J; Gong Q; Shang H
    Parkinsonism Relat Disord; 2016 Jun; 27():41-6. PubMed ID: 27117563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.
    Coppen EM; Jacobs M; van den Berg-Huysmans AA; van der Grond J; Roos RAC
    Parkinsonism Relat Disord; 2018 Jan; 46():56-61. PubMed ID: 29128164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebral blood flow measurements using stable xenon CT with very short inhalation times.
    Touho H; Karasawa J; Shishido H; Yamada K; Shibamoto K
    Neurol Med Chir (Tokyo); 1991 Feb; 31(2):77-81. PubMed ID: 1715040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral blood flow is associated with markers of neurodegeneration in Huntington's disease.
    Rocha NP; Charron O; Colpo GD; Latham LB; Patino JE; Stimming EF; Freeman L; Teixeira AL
    Parkinsonism Relat Disord; 2022 Sep; 102():79-85. PubMed ID: 35973322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical-pathologic correlation in Huntington's disease: a neuropsychological and computed tomography study.
    Bamford KA; Caine ED; Kido DK; Plassche WM; Shoulson I
    Neurology; 1989 Jun; 39(6):796-801. PubMed ID: 2524678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary arginine alters time of symptom onset in Huntington's disease transgenic mice.
    Deckel AW; Volmer P; Weiner R; Gary KA; Covault J; Sasso D; Schmerler N; Watts D; Yan Z; Abeles I
    Brain Res; 2000 Sep; 875(1-2):187-95. PubMed ID: 10967315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional cerebral blood flow and cognitive function in Huntington's disease and schizophrenia. A comparison of patients matched for performance on a prefrontal-type task.
    Goldberg TE; Berman KF; Mohr E; Weinberger DR
    Arch Neurol; 1990 Apr; 47(4):418-22. PubMed ID: 2138883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of cerebral blood flow data obtained by computed tomography (CT) perfusion with that obtained by xenon CT using 320-row CT.
    Takahashi S; Tanizaki Y; Kimura H; Akaji K; Kano T; Suzuki K; Takayama Y; Kanzawa T; Shidoh S; Nakazawa M; Yoshida K; Mihara B
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):635-41. PubMed ID: 25561317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral blood flow changes in hemodialysis and peritoneal dialysis patients: an arterial-spin labeling MR imaging.
    Jiang XL; Wen JQ; Zhang LJ; Zheng G; Li X; Zhang Z; Liu Y; Zheng LJ; Wu L; Chen HJ; Kong X; Luo S; Lu GM; Ji XM; Zhang ZJ
    Metab Brain Dis; 2016 Aug; 31(4):929-36. PubMed ID: 27167984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain atrophy in Huntington's disease. A CT-scan study.
    Starkstein SE; Folstein SE; Brandt J; Pearlson GD; McDonnell A; Folstein M
    Neuroradiology; 1989; 31(2):156-9. PubMed ID: 2526304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional cerebral blood flow in chronic alcoholics measured by single photon emission computerized tomography.
    Melgaard B; Henriksen L; Ahlgren P; Danielsen UT; Sørensen H; Paulson OB
    Acta Neurol Scand; 1990 Aug; 82(2):87-93. PubMed ID: 2256449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease.
    de la Monte SM; Vonsattel JP; Richardson EP
    J Neuropathol Exp Neurol; 1988 Sep; 47(5):516-25. PubMed ID: 2971785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discrimination between patients with mild Alzheimer's disease and healthy subjects based on cerebral blood flow images of the lateral views in xenon-enhanced computed tomography.
    Sase S; Yamamoto H; Kawashima E; Tan X; Sawa Y
    Psychogeriatrics; 2018 Jan; 18(1):3-12. PubMed ID: 28745443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral hypoperfusion correlates with mild and parenchymal loss with severe multi-infarct dementia.
    Kawamura J; Meyer JS; Terayama Y; Weathers S
    J Neurol Sci; 1991 Mar; 102(1):32-8. PubMed ID: 1856730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of stroke rehabilitation outcome with xenon-enhanced computed tomography cerebral blood flow study.
    Araki Y; Furuichi M; Nokura H; Iwata T; Iwama T
    J Stroke Cerebrovasc Dis; 2010; 19(6):450-7. PubMed ID: 20542710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis.
    Kassubek J; Juengling FD; Ecker D; Landwehrmeyer GB
    Cereb Cortex; 2005 Jun; 15(6):846-53. PubMed ID: 15459079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.